[Neoadjuvant treatment of early breast cancer: new drugs contribution]. [electronic resource]
- Bulletin du cancer Dec 2004
- S232-8 p. digital
Publication Type: Journal Article; Review
1769-6917
Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Agents--therapeutic use Breast Neoplasms--drug therapy Bridged-Ring Compounds--therapeutic use Chemotherapy, Adjuvant Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Docetaxel Female Humans Neoadjuvant Therapy Randomized Controlled Trials as Topic Taxoids--therapeutic use Trastuzumab